Effexor is used primarily for the treatment of depression - royaldrugstore

14 May 2014, Saint-Petersburg, (http://royaldrugstore.co/) : Effexor contain Venlafaxine is an antidepressant medication that works in the brain. It is approved for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder (social phobia).

Symptoms of depression include:


Depressed mood - feeling sad, empty, or tearful
Feeling worthless, guilty, hopeless, and helpless
Loss of interest or pleasure in your usual activities
Sleep and eat more or less than usual (for most people it is less)
Low energy, trouble concentrating, or thoughts of death (suicidal thinking)
Psychomotor agitation ('nervous energy')
Psychomotor retardation (feeling like you are moving and thinking in slow motion)
Suicidal thoughts or behaviors

Dosage:


Venlafaxine immediate release tablets are usually taken 2 or 3 times per day with or without food. The extended release tablets and capsules one time per day with or without food.
Typically patients begin at a low dose of medicine and the dose is increased slowly over several weeks.
The dose usually ranges from 37.5 mg to 300 mg. Only your healthcare provider can determine the correct dose for you.
Extended release tablets: swallow whole; do not chew, crush, or break
Consider using a calendar, pillbox, alarm clock, or cell phone alert to help you remember to take your medication. You may also ask a family member or friend to remind you or check in with you to be sure you are taking your medication.

Common Side Effects:


Headache, nausea, diarrhea, dry mouth, increased sweating
Feeling nervous, restless, fatigued, sleepy or having trouble sleeping (insomnia)
These will often improve over the first week or two as you continue to take the medication.
Sexual side effects, such as problems with orgasm or ejaculatory delay
Increased blood pressure These often do not improve over time.

Warning:

Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.


Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications. This risk may persist until significant remission occurs.
In short-term studies, antidepressants increased the risk of suicidality in children, adolescents, and young adults when compared to placebo. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24. Adults age 65 and older taking antidepressants have a decreased risk of suicidality.
Patients, their families, and caregivers should be alert to the emergence of anxiety, restlessness, irritability, aggressiveness and insomnia. If these symptoms emerge, they should be reported to the patient's prescriber or healthcare professional.
All patients being treated with antidepressants for any indication should watch for and notify their healthcare provider for worsening symptoms, suicidality and unusual changes in behavior, especially during the first few months of treatment.

Storage:

Store at room temperature. Protect from heat, light and moisture. Keep away from reach of children.

For more please visit :

James Keneally http://royaldrugstore.co/ Saint-Petersburg, Russia JamesKeneally0122@gmail.com

Hi everyone, this is James Keneally from Australia . I am completed P.HD in pharmacy. I do lots of work in pharmacy but now I am working in royaldrugstore.co. I also write blog on all health related product like Paxil, Allegra ,Kamagra, xenical, protonix, proscar , Meloxicam, Zithromax, Lyrica, etc.